Gamida Cell Ltd. Announces New Supporting Evidence That An Ex-Vivo Expanded Population Of Human Bone Marrow Stem Cells May Help Treat Heart Disease
JERUSALEM--(BUSINESS WIRE)--Jan. 12, 2006-- Data to Be Presented at The Second International Conference on Cell Therapy for Cardiovascular Diseases at the New York Academy of Medicine, January 19, 2006. Gamida Cell Ltd., developer of expanded stem cell therapeutics, announced today that its technology for the ex-vivo expansion of bone marrow-derived stem cells for the treatment of cardiovascular diseases will be presented at The Second International Conference on Cell Therapy for Cardiovascular Diseases at The New York Academy of Medicine, located at 1216 Fifth Avenue, in New York, New York. The presentation will include data collected in 2005, which supports previous evidence that an ex-vivo expanded population of human bone marrow stem cells may help patients who suffer from cardiac disease.